---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-046265"
form_type: "8-K"
ticker: "CBUS"
cik: "0001705843"
company_name: "Cibus, Inc."
filed_at: "2024-11-07T23:59:59+00:00"
generated_at: "2026-05-30T03:39:14.043236+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Cibus Q3 net loss $201.5M on $181.4M goodwill impairment; cash runway into late Q1 2025

## Summary
- Net loss $201.5M ($7.63/sh) vs $34.5M ($1.59/sh) YoY; includes $181.4M non-cash goodwill impairment.
- Cash $28.8M; expects funding into late Q1 2025 without additional financing; board evaluating strategic alternatives.
- Initiating $10M annualized cost savings, reducing monthly cash usage ~20%; one-time severance charge in Q4.
- Rice platform: agreements with 4 seed companies, successful HT3 field trials, stacked gene-edited trait results.
- Soybean platform expected operational by year-end 2024; Sclerotinia resistance field trial positive for second mode of action.

## SEC filing metadata
- accession: 0001628280-24-046265
- form_type: 8-K
- ticker: CBUS
- cik: 0001705843
- company_name: Cibus, Inc.
- filed_at: 2024-11-07T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1705843/000162828024046265/0001628280-24-046265-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1705843/000162828024046265/cbus-20241107.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-046265
- JSON: https://secwatch.observer/filing/0001628280-24-046265.json
- Plain text: https://secwatch.observer/filing/0001628280-24-046265.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.